发明名称
摘要 <p>Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>7 </SUP>are defined in the specification, Z is SO or SO<SUB>2</SUB>, and Ar is an aromatic or heteroaromatic group as defined herein.</p>
申请公布号 JP2005538953(A) 申请公布日期 2005.12.22
申请号 JP20040507462 申请日期 2003.05.28
申请人 发明人
分类号 C07D333/22;A61K31/381;A61K31/404;A61K31/41;A61K31/416;A61K31/4178;A61K31/4184;A61K31/4188;A61K31/422;A61K31/427;A61K31/428;A61K31/4436;A61K31/4439;A61K31/444;A61K31/4535;A61K31/4709;A61K31/496;A61K31/497;A61K31/506;A61K31/513;A61K31/5377;A61K31/662;A61P1/04;A61P3/10;A61P5/14;A61P5/48;A61P7/00;A61P7/06;A61P7/08;A61P7/10;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/02;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/10;A61P21/04;A61P25/00;A61P25/28;A61P29/00;A61P31/00;A61P31/04;A61P37/00;A61P37/06;A61P37/08;A61P41/00;A61P43/00;C07D333/12;C07D333/38;C07D333/54;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D495/04;C07F7/08;C07F7/10;C07F9/6553;(IPC1-7):C07D333/38;C07F9/655;A61K31/537;A61K31/470;A61K31/453;A61K31/443;A61K31/418;A61K31/417 主分类号 C07D333/22
代理机构 代理人
主权项
地址